Filter
3717
Filtered Results: 3717
Text search:
children
in
emergencies
Featured
Recommendations
448
New Publications
1023
Language
Document type
No document type
1957
Studies & Reports
639
Guidelines
496
Manuals
225
Strategic & Response Plan
196
Fact sheets
65
Training Material
61
Situation Updates
49
Brochures
9
Resource Platforms
7
Infographics
7
Online Courses
5
App
1
Countries / Regions
Global
177
India
168
Kenya
95
Syria
87
Myanmar / Burma
82
Sierra Leone
81
Nepal
80
Ethiopia
80
Liberia
74
Uganda
62
Nigeria
61
Bangladesh
60
South Africa
57
Latin America and the Carribbean
56
Western and Central Europe
56
South Sudan
54
Africa
47
Tanzania
38
Congo, Democratic Republic of
38
Malawi
37
Ukraine
35
Ghana
35
Rwanda
33
Zambia
31
Philippines
30
Mozambique
27
Yemen
27
Haiti
26
Namibia
26
South–East Asia Region
25
Venezuela
24
Indonesia
23
Zimbabwe
22
Afghanistan
21
Guinea
20
Asia
20
Cambodia
19
Senegal
18
Middle East and North Africa
18
Brazil
18
Germany
17
West and Central Africa
17
East and Southern Africa
17
Sudan
16
Somalia
16
Pakistan
16
Jordan
15
Colombia
14
Lesotho
14
Eastern Europe
14
Eastern Europe and Central Asia
13
Lebanon
13
Vietnam
12
Central African Republic
11
USA
10
Russia
10
Iraq
10
Turkey
9
Laos
9
Western Pacific Region
9
Eswatini/ Swaziland
9
Burkina Faso
8
Ecuador
8
Madagascar
8
China
7
Iran
7
Spain
7
Botswana
7
Thailand
6
Cameroon
6
Peru
6
Moldova
6
Mali
6
Angola
6
Paraguay
5
Papua New Guinea
5
Egypt
5
Libya
5
Chile
4
Niger
4
Burundi
4
Saudi Arabia
4
Turkmenistan
4
Portugal
4
Argentina
4
Sri Lanka
4
Bhutan
4
North Korea
3
Timor Leste/ East Timor
3
Togo
3
Malaysia
3
Japan
3
Mauritius
3
Southern Africa
3
Côte d’Ivoire / Ivory Coast
3
Greece
3
Palestine
3
Georgia
3
Serbia
2
Benin
2
Albania
2
Fiji
2
Morocco
2
Italy
2
Croatia
2
North America
2
Tunisia
2
South Korea
2
Bolivia
2
North Macedonia
1
Tajikistan
1
Switzerland
1
Mexico
1
El Salvador
1
Gambia
1
Kazakhstan
1
Singapore
1
Kyrgyzstan
1
Uzbekistan
1
Vanuatu
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Hungary
1
Gabon
1
France
1
Maldives
1
United Kingdom
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Djibouti
1
Romania
1
Poland
1
Honduras
1
Chad
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1334
Clinical Guidelines
275
Key Resources
266
Women & Child Health
235
Public Health
198
Capacity Building
76
Pharmacy & Technologies
21
Annual Report MEDBOX
1
Toolboxes
COVID-19
414
Mental Health
280
Conflict
215
Rapid Response
154
HIV
138
Disability
137
Planetary Health
137
TB
131
Natural Hazards
123
Refugee
118
AMR
118
Ebola
110
Caregiver
85
Global Health Education
67
NTDs
62
Pharmacy
50
Cholera
39
Polio
39
NCDs
36
Specific Hazards
32
Health Financing Toolbox
28
Zika
28
Social Ethics
8
Typhoon
4
South Sudan
2
The disaster and Red Cross Red Crescent response to date
9 March 2019: Tropical Cyclone Idai forms over Northern Mozambique Channel. CVM preparedness and early warning actions underway
13 March 2019: IFRC Surge Capacity is deployed to Maputo
14 March 2019: 342,562 Swiss francs allocated from th...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Every country has been affected by COVID-19, with nearly a quarter
of a billion cases and almost 5 million deaths reported globally as of
end of September 2021. Despite the stunning speed with which highly
effective and safe vaccines have been developed, new waves of disease
are still pushin...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i....
A Reference Guide for Program Managers and Policy Makers. Recently, a renewed interest in large-scale community health worker (CHW) programs has been seen globally. This renewal provides an opportune moment to take stock of issues and challenges such programs face and what can be done to make them a...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
This report provides a synthesis of some of the most recent, high-quality literature on the security and political processes in Central African Republic produced up to the end of January 2016. It was prepared for the European Union’s Instrument Contributing to Stability and Peace, © European Unio...
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ...
As part of our commitment to the fight against NCDs, Nigeria was signatory to the political declaration at the UN General Assembly High Level Meeting on NCDs in September 2011. Thus, the purpose of this document is to develop and ensure the implementation of policies and p...
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
